Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0352 | 0.3053 | 0.6976 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0384 | 0.3391 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0134 | 0.0693 | 0.7501 |
Loa Loa (eye worm) | hypothetical protein | 0.0325 | 0.2752 | 0.6288 |
Echinococcus granulosus | tar DNA binding protein | 0.0352 | 0.3053 | 0.9005 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0352 | 0.3053 | 0.6976 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0384 | 0.3391 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.015 | 0.0867 | 0.1981 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.007 | 0 | 0.5 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.007 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.007 | 0 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0325 | 0.2752 | 0.6288 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0475 | 0.4377 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0257 | 0.2018 | 0.461 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.007 | 0 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0384 | 0.3391 | 1 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0925 | 0.9242 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0352 | 0.3053 | 0.6976 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.0867 | 0.1981 |
Echinococcus multilocularis | amiloride sensitive amine oxidase | 0.0286 | 0.2336 | 0.6888 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.015 | 0.0867 | 0.2557 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.015 | 0.0867 | 0.2557 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.015 | 0.0867 | 0.2557 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0362 | 0.316 | 0.9319 |
Schistosoma mansoni | copper/topaquinone oxidase | 0.0286 | 0.2336 | 0.6888 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0475 | 0.4377 | 1 |
Onchocerca volvulus | 0.007 | 0 | 0.5 | |
Brugia malayi | RNA binding protein | 0.0352 | 0.3053 | 0.6976 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Brugia malayi | MH2 domain containing protein | 0.0257 | 0.2018 | 0.461 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.007 | 0 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.015 | 0.0867 | 0.2557 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0475 | 0.4377 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0995 | 1 | 1 |
Toxoplasma gondii | hypothetical protein | 0.0145 | 0.0805 | 0.8717 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.007 | 0 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0384 | 0.3391 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.015 | 0.0867 | 0.2557 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Brugia malayi | TAR-binding protein | 0.0352 | 0.3053 | 0.6976 |
Brugia malayi | kinase, mitochondrial precursor | 0.0384 | 0.3391 | 0.7747 |
Schistosoma mansoni | hypothetical protein | 0.0286 | 0.2336 | 0.6888 |
Echinococcus granulosus | amiloride sensitive amine oxidase | 0.0286 | 0.2336 | 0.6888 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.007 | 0 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.015 | 0.0867 | 0.2557 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.007 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0384 | 0.3391 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0475 | 0.4377 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Echinococcus multilocularis | tar DNA binding protein | 0.0352 | 0.3053 | 0.9005 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.015 | 0.0867 | 0.1981 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.0867 | 0.2557 |
Loa Loa (eye worm) | hypothetical protein | 0.0384 | 0.3391 | 0.7747 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0155 | 0.0923 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.015 | 0.0867 | 0.1981 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0362 | 0.316 | 0.9319 |
Schistosoma mansoni | hypothetical protein | 0.0325 | 0.2752 | 0.8117 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Schistosoma mansoni | tar DNA-binding protein | 0.0352 | 0.3053 | 0.9005 |
Loa Loa (eye worm) | TAR-binding protein | 0.0352 | 0.3053 | 0.6976 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0134 | 0.0693 | 0.2043 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0134 | 0.0693 | 0.2043 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0384 | 0.3391 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.007 | 0 | 0.5 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0384 | 0.3391 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0257 | 0.2018 | 0.461 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.